ÖÐÎÄÃû³Æ£º Íÿ¹MED12¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-MED12 rabbit polyclonal antibody
±ð Ãû£º OKS; FGS1; HOPA; OPA1; OHDOX; ARC240; CAGH45; MED12S; TNRC11; TRAP230
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£©
ËÞ Ö÷£º Rabbit
¿¹ Ô£º MED12
·´Ó¦ÖÖÊô£º Human, Mouse
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
|
Background: |
The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. |
|
Applications: |
ELISA, IHC |
|
Name of antibody: |
MED12 |
|
Immunogen: |
Synthetic peptide of human MED12 |
|
Full name: |
mediator complex subunit 12 |
|
Synonyms£º |
OKS; FGS1; HOPA; OPA1; OHDOX; ARC240; CAGH45; MED12S; TNRC11; TRAP230 |
|
SwissProt: |
Q93074 |
|
ELISA Recommended dilution: |
2000-5000 |
|
IHC positive control: |
Human breast cancer |
|
IHC Recommend dilution: |
25-100 |

¹ºÎï³µ
°ïÖú
021-54845833/15800441009
